Change language:
Krystal Biotech has been focused on protecting inventions in United States(US) with four publications in Q4 2023
The United States Patent Office dominates patent applications and grants, with approximately 43% of applications and one hundred percent of grants. The patent offices of the United States (US), Australia (AU), Chile (CL), and Israel (IL) are among the ten most sensible patent offices with which Krystal Biotech files its patents. Among the top patent authorities, Krystal Biotech gives one hundred percent of its grants to the United States.
Amgen and Replimune Group may be Krystal Biotech’s most powerful competitors
Genomics and rare patents dominate Krystal Biotech’s portfolio
Krystal Biotech holds the largest number of patents in genomics, followed by rare diseases. In genomics, almost 50% of patents have been filed and one hundred percent of patents have been granted in the fourth quarter of 2023.
Lung cancer related patents lead Krystal Biotech portfolio followed by nonmelanomatous skin cancer, and secondary cns lymphoma
Krystal Biotech holds the largest number of patents in lung cancer, followed by non-melanoma skin cancer, secondary CNS lymphoma, non-small mobile lung cancer, and extrahepatic bile duct cancer. For lung cancer, only about 3% of patents were filed and 1% of patents were granted in the fourth quarter of 2023.
For comprehensive analysis of Krystal Biotech’s filings and grants, buy the databook here.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
The patent database further removes ambiguity from assignee names (13 million names) and the hierarchy of the related corporate tree in current or at a particular point in time (320,000 entities). Content from GlobalData resources directly from the week of national patent offices.
The reference in intelligence.
Check out all newsletters from the GlobalData Media network.